Vascular dementia testing is not one single test. It is a careful workup that looks for two things at the same time: clear changes in thinking or daily function, and evidence that blood vessel disease in the brain is likely contributing to those changes.
That distinction matters. Memory loss, slowed thinking, confusion, poor concentration, and behavior changes can come from many causes, including Alzheimer’s disease, depression, delirium, medication effects, sleep problems, vitamin deficiencies, thyroid disease, stroke, and mixed forms of dementia. A good evaluation does not simply “look for dementia.” It tries to understand the pattern, cause, severity, safety risks, and next steps.
Table of Contents
- What Vascular Dementia Testing Checks
- First Appointment, History, and Exam
- Cognitive Tests and Neuropsychological Testing
- Brain Scans Used in Vascular Dementia Testing
- Lab Tests and Checks for Other Causes
- How Doctors Interpret Results
- What Happens After Testing
What Vascular Dementia Testing Checks
Vascular dementia testing checks whether cognitive problems are linked to stroke, small vessel disease, reduced blood flow, bleeding, or other vascular injury in the brain. The diagnosis usually depends on a pattern: measurable cognitive decline, evidence of cerebrovascular disease, and a plausible connection between the two.
The term “vascular dementia” is often used when cognitive impairment is significant enough to interfere with independence. Clinicians may also use “vascular cognitive impairment” for a broader range of problems, from mild cognitive changes to major impairment. This broader term is useful because vascular brain injury does not always produce the same memory-first pattern people often associate with dementia.
Common symptoms can include:
- Slower thinking or mental processing
- Trouble planning, organizing, or switching between tasks
- Reduced attention or concentration
- Difficulty managing finances, medications, cooking, driving, or appointments
- Changes in walking, balance, urinary urgency, mood, or emotional control
- Memory problems, especially when vascular disease overlaps with Alzheimer’s disease
Some people develop symptoms suddenly after a stroke. Others notice a gradual decline related to small vessel disease, repeated silent infarcts, or mixed brain changes. The older “stepwise decline” pattern can occur, but it is not present in every case.
Testing also looks for conditions that can mimic or worsen vascular dementia. Delirium, depression, medication side effects, untreated sleep apnea, low vitamin B12, thyroid disease, hearing loss, vision problems, and poorly controlled blood sugar can all affect thinking. A person may have more than one contributor at the same time, which is why a complete workup is often more useful than a single screening score.
A helpful starting point is a broader dementia screening workup, especially when symptoms are new, progressive, or affecting daily life. Screening does not prove the cause, but it helps decide whether more detailed testing or specialist referral is needed.
Urgent symptoms should be handled differently. Sudden face drooping, arm weakness, speech trouble, new vision loss, severe dizziness, loss of balance, or a sudden severe headache may signal a stroke or transient ischemic attack. Those symptoms need emergency evaluation rather than a routine memory appointment.
First Appointment, History, and Exam
The first part of testing is usually a detailed history, physical exam, neurological exam, and review of daily functioning. This step is essential because the timing and pattern of symptoms often reveal more than a single test score.
Clinicians usually ask when symptoms began, whether they appeared suddenly or gradually, and whether there were clear events such as stroke, transient ischemic attack, heart surgery, hospitalization, falls, head injury, or major illness. They may ask whether symptoms fluctuate from day to day, worsen in the evening, or changed after starting a new medication.
A family member, partner, or close friend can be especially helpful. People with cognitive impairment may not notice all changes, or they may underestimate how much support they now need. A collateral history can clarify whether the person is missing bills, repeating questions, getting lost, making unsafe decisions, forgetting medications, or struggling with tasks that used to be easy.
The medical history also focuses on vascular risk factors. These may include high blood pressure, diabetes, high cholesterol, smoking, atrial fibrillation, heart disease, prior stroke, kidney disease, sleep apnea, and limited physical activity. These details matter because vascular dementia testing is not only about naming the condition. It also identifies risks that may be treatable.
A neurological exam may check:
- Strength, reflexes, sensation, and coordination
- Walking pattern, balance, and fall risk
- Eye movements and visual fields
- Speech, language, and swallowing clues
- Signs of Parkinsonism, prior stroke, neuropathy, or other neurological disease
The clinician will also review medications. Drugs with sedating or anticholinergic effects can worsen memory and attention, especially in older adults. Examples may include some sleep aids, bladder medications, older antihistamines, muscle relaxants, certain pain medicines, and some psychiatric medications. Stopping or changing medicines should be done with a clinician, not abruptly.
Mood and sleep are part of the evaluation too. Depression can cause slowed thinking, poor concentration, low motivation, and memory complaints. Sleep apnea can cause daytime sleepiness, brain fog, and attention problems. When the picture is unclear, comparisons such as depression versus dementia can help families understand why doctors ask about mood, motivation, appetite, sleep, and stress rather than focusing only on memory.
Cognitive Tests and Neuropsychological Testing
Cognitive testing measures the thinking skills that may be affected by vascular brain injury, including attention, processing speed, executive function, memory, language, and visuospatial ability. Brief tests are useful for screening, while neuropsychological testing gives a more detailed map of strengths and weaknesses.
In primary care or a memory clinic, a clinician may use tools such as the Mini-Cog, MoCA, MMSE, SLUMS, or other structured cognitive instruments. These tests may include tasks such as remembering words, drawing a clock, naming objects, following instructions, doing mental calculations, repeating phrases, or switching between numbers and letters.
A low score does not automatically mean vascular dementia. Scores can be affected by education, language, hearing, vision, pain, anxiety, depression, fatigue, cultural background, and test conditions. A normal score also does not fully rule out early disease, especially when a person has high baseline ability or mainly executive-function problems.
Vascular cognitive impairment often affects executive function and speed of thinking. That means a person may know information but take longer to process it, organize it, or apply it to real-life tasks. For example, they may still recognize family members and remember major life events, but struggle to manage bills, plan a meal, follow a multi-step conversation, or respond quickly while driving.
More detailed neuropsychological testing for dementia and memory loss may be recommended when brief screening is inconclusive, symptoms are subtle, the person is younger than expected for dementia, work or legal decisions depend on the results, or the diagnosis could be Alzheimer’s disease, frontotemporal dementia, Lewy body dementia, vascular cognitive impairment, depression, or another condition.
Neuropsychological testing may assess:
- Attention and working memory
- Processing speed
- Verbal and visual memory
- Problem-solving and mental flexibility
- Language and naming
- Visual-spatial reasoning
- Judgment, inhibition, and planning
- Mood and effort factors that can affect performance
The results can help distinguish a mostly vascular pattern from a more typical Alzheimer’s pattern. Alzheimer’s disease often begins with prominent new-learning and episodic memory problems, while vascular cognitive impairment may show more slowing, attention difficulty, and executive dysfunction. In real life, the pattern is often mixed, especially in older adults.
Families may find it useful to understand common cognitive test scores, but scores should be interpreted by a professional who knows the person’s background, symptoms, and medical context. A score is one piece of the diagnosis, not the diagnosis itself.
Brain Scans Used in Vascular Dementia Testing
Brain imaging is one of the most important parts of vascular dementia testing because it can show strokes, small vessel disease, bleeding, tumors, fluid buildup, and other structural causes of cognitive decline. MRI is usually preferred when vascular dementia is suspected, but CT is still useful in many situations.
A brain scan does not diagnose vascular dementia by itself. Many older adults have some white matter changes or small vascular lesions without dementia. The key question is whether the type, location, and burden of vascular injury match the person’s symptoms and cognitive testing pattern.
MRI can show details that CT may miss, including small infarcts, lacunes, microbleeds, white matter hyperintensities, and patterns of atrophy. MRI sequences can help identify small vessel disease, prior bleeding, strategic infarcts, and other changes that may affect cognition. A brain MRI is often the most informative structural scan when the person can safely have one.
CT uses X-rays and is faster, more available, and often easier for people who cannot tolerate MRI. It can detect many strokes, bleeding, tumors, hydrocephalus, and significant atrophy. A brain CT scan may be chosen when MRI is contraindicated because of certain implanted devices, severe claustrophobia, inability to lie still, or urgent clinical circumstances.
| Test | What it can show | When it may be used |
|---|---|---|
| MRI brain | Small strokes, lacunes, white matter disease, microbleeds, atrophy, structural lesions | Often preferred when vascular dementia or mixed dementia is suspected |
| CT brain | Larger strokes, bleeding, mass lesions, hydrocephalus, significant atrophy | Used when MRI is unavailable, contraindicated, urgent, or not tolerated |
| FDG-PET or perfusion SPECT | Patterns of brain metabolism or blood flow | Sometimes used by specialists when the dementia subtype remains unclear |
| Amyloid or tau PET | Evidence of Alzheimer’s-related amyloid or tau pathology | Considered when Alzheimer’s disease or mixed dementia is a key diagnostic question |
| Carotid or vascular imaging | Narrowing or disease in blood vessels supplying the brain | Used selectively, especially after stroke symptoms or when vascular management may change |
PET and SPECT are not routine first-line tests for most suspected vascular dementia cases. They are more often considered when specialists need help distinguishing Alzheimer’s disease, frontotemporal dementia, Lewy body dementia, or mixed disease after structural imaging and clinical assessment.
Brain imaging for cognitive symptoms is best understood as part of a larger workup. The same MRI finding can mean different things depending on age, symptoms, risk factors, neurological exam, and cognitive profile. For a broader comparison, brain imaging for memory loss can help clarify when MRI, CT, PET, or other scans are considered.
Lab Tests and Checks for Other Causes
Blood and urine tests do not diagnose vascular dementia directly, but they help identify treatable problems that can cause or worsen cognitive symptoms. They also help assess vascular risk factors that may influence future stroke risk and brain health.
A typical lab workup may include tests for anemia, infection, kidney or liver problems, electrolytes, thyroid disease, vitamin B12 deficiency, folate deficiency, diabetes, and other medical issues depending on the person’s symptoms and history. Some clinicians also check inflammatory markers, medication levels, or tests related to autoimmune, infectious, or nutritional conditions when the presentation is unusual.
Commonly considered tests include:
- Complete blood count
- Comprehensive metabolic panel
- Thyroid-stimulating hormone
- Vitamin B12, and sometimes folate
- A1C or fasting glucose
- Lipid panel
- Urinalysis when infection or delirium is possible
- Tests for sleep apnea, when symptoms suggest it
- Hearing and vision checks, when sensory problems may affect testing or daily function
These tests are especially important when symptoms come on quickly, fluctuate, or do not fit a typical dementia pattern. Delirium, for example, can cause sudden confusion and may be related to infection, dehydration, medication effects, metabolic problems, pain, or hospitalization. Delirium is a medical problem that needs prompt evaluation.
No standard blood test can confirm vascular dementia. Blood biomarkers are developing rapidly for Alzheimer’s disease and other neurodegenerative conditions, but vascular cognitive impairment still depends heavily on clinical assessment, cognitive testing, and brain imaging. Alzheimer’s biomarker tests may be useful when mixed dementia is suspected, because vascular disease and Alzheimer’s pathology often occur together.
A detailed memory loss lab workup can also help families understand why doctors order tests that may seem unrelated to the brain. The goal is not to “find dementia in the blood.” The goal is to avoid missing reversible or treatable contributors.
Other checks may be added based on the clinical picture. If atrial fibrillation is suspected, the clinician may order an electrocardiogram or longer heart rhythm monitoring. If sleep apnea is likely, a sleep study may be recommended. If there are repeated falls, gait changes, urinary symptoms, or concern for normal pressure hydrocephalus, imaging and specialist evaluation may focus on those clues.
How Doctors Interpret Results
Doctors interpret vascular dementia testing by combining symptoms, daily functioning, cognitive results, neurological findings, and brain imaging. A diagnosis is strongest when these pieces point in the same direction.
For example, a person who had a stroke followed by new problems with planning, attention, processing speed, and daily independence may have a clearer vascular link. Another person may have gradual memory loss, mild white matter changes, and positive Alzheimer’s biomarkers, suggesting Alzheimer’s disease with vascular changes rather than purely vascular dementia. A third person may have both meaningful vascular injury and Alzheimer’s-type changes, leading to a mixed diagnosis.
Imaging reports often use terms that sound alarming but need context. White matter hyperintensities, chronic microvascular ischemic changes, lacunar infarcts, chronic small vessel disease, microbleeds, and cerebral atrophy are common examples. These findings can be important, but they do not all carry the same meaning.
A small amount of age-related white matter change may not explain major cognitive impairment. On the other hand, extensive small vessel disease, multiple lacunes, strategic strokes in key cognitive networks, or vascular injury combined with neurodegenerative disease may have a major effect.
Doctors also consider whether symptoms are severe enough to meet criteria for dementia. Mild vascular cognitive impairment may affect testing or complex tasks but not basic independence. Vascular dementia, or major vascular neurocognitive disorder, generally implies that cognitive decline interferes with independent daily life.
The diagnostic process may include several possibilities:
- Probable vascular cognitive impairment or vascular dementia
- Possible vascular contribution, with more information needed
- Mixed dementia, often involving vascular disease plus Alzheimer’s disease
- Cognitive symptoms mainly due to another condition
- Mild cognitive impairment with vascular risk factors
- Delirium, depression, sleep disorder, medication effect, or another reversible contributor
It is reasonable to ask the clinician to explain the results in plain language. Useful questions include: What cognitive domains are affected? What did the scan show? Are the scan findings enough to explain the symptoms? Is Alzheimer’s disease also possible? Are there treatable contributors? What should be monitored over time?
When results are abnormal, a structured follow-up plan is important. Abnormal cognitive test or brain scan results do not always mean a person has irreversible dementia, but they do need careful interpretation and next steps.
What Happens After Testing
After testing, the next step is usually a clear diagnosis, a risk-reduction plan, support for daily function, and follow-up over time. Even when vascular cognitive impairment cannot be reversed, identifying it can help prevent further vascular injury and improve safety.
Management often focuses on vascular risk factors. Depending on the person’s situation, this may include better blood pressure control, diabetes management, cholesterol treatment, smoking cessation, physical activity, nutrition changes, treatment of sleep apnea, and appropriate stroke prevention. Medications such as antiplatelet drugs, anticoagulants, statins, or blood pressure medicines may be considered when indicated for the person’s cardiovascular or stroke risk profile.
Cognitive and functional support matters too. Occupational therapy, speech-language therapy, physical therapy, medication organization, driving assessment, fall prevention, hearing and vision correction, and caregiver education may all be useful. The goal is not only to label the condition but to help the person function as safely and independently as possible.
Follow-up testing may track whether cognition is stable, improving after treatment of contributors, or declining over time. Repeat cognitive testing can show patterns that one appointment cannot. Repeat imaging is not always needed, but it may be considered after new neurological symptoms, rapid worsening, suspected stroke, or a change in diagnosis.
Families should also discuss legal and practical planning early, while the person can participate as much as possible. This may include medication management, financial oversight, driving, home safety, advance care planning, and identifying who can help with medical decisions if cognition worsens.
Specialist referral may be appropriate when the diagnosis is uncertain, symptoms begin at a younger age, decline is rapid, hallucinations or major behavior changes are present, seizures occur, movement problems are prominent, or the person has complex stroke, heart, or psychiatric history. Neurologists, geriatricians, psychiatrists, neuropsychologists, and memory clinics may each contribute different parts of the workup.
Testing can feel stressful, especially when a family is waiting for answers. A useful goal is to leave the evaluation with four practical pieces of information: what is most likely causing the symptoms, what can be treated or modified, what safety issues need attention now, and how the condition will be monitored.
References
- Revised Diagnostic Criteria for Vascular Cognitive Impairment and Dementia—The VasCog-2-WSO Criteria 2025 (Consensus Criteria)
- ACR Appropriateness Criteria® Dementia: 2024 Update 2025 (Guideline)
- Clinical practice guidelines on addressing cognitive impairment in vascular dementias 2025 (Guideline)
- Diagnosing vascular cognitive impairment: Current challenges and future perspectives 2023 (Review)
- Dementia: assessment, management and support for people living with dementia and their carers 2018 (Guideline)
- Signs and Symptoms of Stroke 2024 (Government Health Resource)
Disclaimer
This article is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. New or worsening confusion, sudden weakness, speech trouble, vision changes, severe dizziness, or other possible stroke symptoms require urgent medical evaluation.
Share this article on Facebook, X, or your preferred platform to help others understand how vascular dementia testing and brain scans fit into a careful cognitive workup.
